Statistics about Society in United Kingdom
Statistics
- Hemogenyx Pharmaceuticals net income 2020-2025
- Ironveld total assets 2020-2025
- Renalytix net income 2022-2025
- World Chess total assets 2020-2025
- Industry revenue of research, experimental development on biotech in the UK 2012-2025
- Physiomics revenue 2019-2025
- Physiomics total assets 2019-2025
- Physiomics net income 2019-2025
- Physiomics total equity 2019-2025
- Bivictrix Therapeutics Limited total assets 2021-2024
- Bivictrix Therapeutics Limited total equity 2021-2024
- Bivictrix Therapeutics Limited net income 2021-2024
- Adaptimmune Therapeutics revenue 2020-2024
- Graft Polymer (Uk) total assets 2021-2024
- Graft Polymer (Uk) net income 2021-2024
- Graft Polymer (Uk) revenue 2021-2024
- Graft Polymer (Uk) total equity 2021-2024
- Roquefort Therapeutics total equity 2021-2024
- Adaptimmune Therapeutics total assets 2020-2024
- Xeros Technology Group revenue 2020-2024
- Adaptimmune Therapeutics total equity 2020-2024
- Xeros Technology Group net income 2020-2024
- Adaptimmune Therapeutics net income 2020-2024
- Xeros Technology Group total assets 2020-2024
- Roquefort Therapeutics net income 2021-2024
- Oxford Nanopore Technologies total equity 2021-2024
- Eenergy Group total equity 2020-2024
- Synairgen total equity 2020-2024
- Directa Plus total equity 2019-2024
- Oxford Nanopore Technologies revenue 2021-2024
- Eenergy Group net income 2020-2024
- Eenergy Group revenue 2020-2024
- Synairgen total assets 2020-2024
- Synairgen net income 2020-2024
- Oxford Nanopore Technologies total assets 2021-2024
- Oxford Nanopore Technologies net income 2021-2024
- Directa Plus total assets 2019-2024
- Eenergy Group total assets 2020-2024
- Directa Plus revenue 2019-2024
- Directa Plus net income 2019-2024
- Tiger Royalties And Investments net income 2021-2024
- Trailfinders Group total equity 2019-2023
- Trailfinders Group net income 2019-2023
- Trailfinders Group revenue 2019-2023
- Helium Ventures net income 2021-2022
- Diaceutics total assets 2019-2023
- Diaceutics revenue 2019-2023
- Diaceutics total equity 2019-2023
- Diaceutics net income 2019-2023
- Inspired total assets 2019-2021
- Inspired total equity 2019-2021
- Inspired net income 2019-2021
- Valirx total assets 2020-2023
- Valirx total equity 2020-2023
- Nucana net income 2019-2020
- Valirx net income 2020-2023
- 4Basebio total assets 2021-2023
- 4Basebio revenue 2021-2023
- 4Basebio total equity 2021-2023
- 4Basebio net income 2021-2023
- World Chess net income 2019-2023
- Sdi Group total assets 2019-2023
- Sdi Group revenue 2019-2023
- Xeros Technology Group total equity 2019-2021
- Sdi Group total equity 2019-2023
- Ao World total assets 2021-2023
- Verona Pharma total assets 2020-2024
- Ao World revenue 2021-2023
- Verona Pharma revenue 2021-2024
- Ao World total equity 2021-2023
- Verona Pharma total equity 2020-2024
- Ao World net income 2021-2023
- Verona Pharma net income 2020-2024
- Sdi Group net income 2019-2023
- Nanoco Group total assets 2020-2023
- Frenkel Topping Group total assets 2019-2023
- Tristel total assets 2019-2023
- Ncc Group total assets 2019-2022
- Nanoco Group revenue 2020-2023
- Tristel revenue 2019-2023
- Frenkel Topping Group revenue 2019-2023
- Ncc Group revenue 2019-2022
- Nanoco Group total equity 2020-2023
- Tristel total equity 2019-2023
- Frenkel Topping Group total equity 2019-2023
- Ncc Group total equity 2019-2022
- Nanoco Group net income 2020-2023
- Tristel net income 2019-2023
- Frenkel Topping Group net income 2019-2023
- Ncc Group net income 2019-2022
- Active Energy Group total assets 2019-2022
- Active Energy Group revenue 2019-2021
- Active Energy Group total equity 2019-2022
- Active Energy Group net income 2019-2022
- Eden Research total assets 2020-2023
- Silence Therapeutics total assets 2021-2023
- Eden Research revenue 2020-2023
- Silence Therapeutics revenue 2020-2023
- Eden Research total equity 2020-2022
- Silence Therapeutics total equity 2020-2023